Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical LDE225 in NBCCS-associated BCC
NCT03070691Phase 3Withdrawn
- Sponsor
- Novartis
- Modality
- Allosteric Modulators
- Countries
- 10
01
Overview
A Phase 3 trial of sonidegib in basal cell carcinoma (BCC), sponsored by Novartis. Status: withdrawn.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT03070691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070691.